Ibandron (Ibandronic Acid)

Therapeutic Group : NSAID & Analgesic Presentation: Ibandron Tablet: Each film coated tablet contains Ibandronate Sodium INN equivalent to Ibandronic Acid 150 mg. Indications: Ibandron is indicated for the treatment and prevention of osteoporosis in postmenopausal women. Ibandron increases bone mineral density (BMD) and reduces the incidence of vertebral fractures. Dosage & Administration: The dose […]

I-Gold (Antioxidant Eye Vitamins)

Therapeutic Group : Eye Vitamin Presentation: I-Gold Capsule: Each capsule contains Vitamin C USP 60 mg, Vitamin E USP 30 mg, Zinc (as Zinc Oxide) USP 15 mg, Lutein 6 mg and Copper (as Cupric Oxide) 2 mg. Pharmacology: Vitamin C & Vitamin E work as antioxidants and they have free radicals scavenging property. Lutein […]

Hypomer Gel (Hypromellose)

Therapeutic Group : Dry Eye Product Presentation: Hypomer Gel: Each gram contains Hypromellose USP 3 mg (enriched with Carbomer 980 USP 0.22%). Pharmacology: Hypomer Gel is a long acting eye gel for lubricating the surface of the eye for all patients with ocular discomfort. The slight hypotonicity of the gel is rapidly “neutralised” by the […]

Hepamarin-140 (Silymarin)

Therapeutic Group : Herbal Pharmacology: Silymarin possesses hepatoprotective and antioxidant activity. The hepatoprotective effect is due to the stimulation of synthesis of structural and functional proteins and phospholipids, as well as the acceleration of the regeneration of hepatocytes. The antioxidant effect is determined by bioflavonoids’ interaction with free radicals in the liver and its detoxication. […]

HemHemo(Tranexamic Acid)

Therapeutic Group : Antifibrinolytic Agent Presentation: Hemostat Capsule: Each capsule contains Tranexamic Acid BP 500 mg.Hemostat Injection: Each 5 ml ampoule contains Tranexamic Acid BP 250 mg. Indications: Short-term use for haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis.1. Local fibrinolysis occurs in the following conditions: Prostatectomy and bladder surgery, Menorrhagia, Epistaxis ,Conisation […]

Gynoxin (Neomycin, Polymyxin B, Nystatin & Metronidazole)

Therapeutic Group : Antibiotic + Steroid Presentation: Gynoxin Vaginal Suppository: Each suppository contains Neomycin Sulphate BP 51.47 mg equivalent to Neomycin 35000 IU, Polymyxin B Sulphate BP 5 mg equivalent to Polymyxin B 35000 IU, Nystatin BP 20 mg equivalent to Nystatin 100000 IU and Metronidazole BP 200 mg. Indications: Gynoxin is indicated in vaginal […]

Gluvan Plus (Vildagliptin + Metformin Hydrochloride)

Therapeutic Group : Antidiabetic Presentation: Gluvan Plus 500 Tablet: Each film coated tablet contains Vildagliptin INN 50 mg & Metformin Hydrochloride BP 500 mg.Gluvan Plus 850 Tablet: Each film coated tablet contains Vildagliptin INN 50 mg & Metformin Hydrochloride BP 850 mg. Indications: Gluvan Plus is indicated as an adjunct to diet and exercises to […]

Gluvan (Vildagliptin)

Therapeutic Group : Antidiabetic Presentation: Gluvan Tablet: Each tablet contains Vildagliptin INN 50 mg. Indications: Gluvan is indicated for the treatment of type 2 diabetes mellitus.•As monotherapy.•In dual combination with Metformin, a Sulfonylurea, a Thiazolidinedione or Insulin when diet, exercise and a single antidiabetic agent do not result in adequate glycemic control. Dosage & Administration: […]

Glucozid (Gliclazide)

Therapeutic Group : Antidiabetic Presentation: Glucozid Tablet: Each Glucozid tablet contains Gliclazide BP 80 mg. Indications: Glucozid (Gliclazide) is indicated for control of blood glucose in patients with non-insulin dependent diabetes mellitus (Type-II, maturity onset diabetes mellitus) whose hyperglycemia cannot be controlled by diet alone. Dosage & Administration: Initially, 40-80 mg daily adjusted according to […]

Gluconor (Glimepiride)

Therapeutic Group : Antidiabetic Presentation: Gluconor-1 Tablet: Each tablet contains Glimepiride USP 1 mg.Gluconor-2 Tablet: Each tablet contains Glimepiride USP 2 mg. Indications: Gluconor is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non-insulin dependent diabetes mellitus whose hyperglycaemia cannot be controlled by diet and exercise alone. […]